Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

719 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Lower serum sodium is associated with increased short-term mortality in hospitalized patients with worsening heart failure: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) study.
Klein L, O'Connor CM, Leimberger JD, Gattis-Stough W, Piña IL, Felker GM, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators. Klein L, et al. Among authors: gheorghiade m. Circulation. 2005 May 17;111(19):2454-60. doi: 10.1161/01.CIR.0000165065.82609.3D. Epub 2005 May 2. Circulation. 2005. PMID: 15867182 Clinical Trial.
Digoxin in the management of cardiovascular disorders.
Gheorghiade M, Adams KF Jr, Colucci WS. Gheorghiade M, et al. Circulation. 2004 Jun 22;109(24):2959-64. doi: 10.1161/01.CIR.0000132482.95686.87. Circulation. 2004. PMID: 15210613 Review. No abstract available.
Coronary artery disease and prevention of heart failure.
Klein L, Gheorghiade M. Klein L, et al. Among authors: gheorghiade m. Med Clin North Am. 2004 Sep;88(5):1209-35. doi: 10.1016/j.mcna.2004.03.002. Med Clin North Am. 2004. PMID: 15331314 Review.
Acute heart failure syndromes: current state and framework for future research.
Gheorghiade M, Zannad F, Sopko G, Klein L, Piña IL, Konstam MA, Massie BM, Roland E, Targum S, Collins SP, Filippatos G, Tavazzi L; International Working Group on Acute Heart Failure Syndromes. Gheorghiade M, et al. Circulation. 2005 Dec 20;112(25):3958-68. doi: 10.1161/CIRCULATIONAHA.105.590091. Circulation. 2005. PMID: 16365214 No abstract available.
Improvement in hyponatremia during hospitalization for worsening heart failure is associated with improved outcomes: insights from the Acute and Chronic Therapeutic Impact of a Vasopressin Antagonist in Chronic Heart Failure (ACTIV in CHF) trial.
Rossi J, Bayram M, Udelson JE, Lloyd-Jones D, Adams KF, Oconnor CM, Stough WG, Ouyang J, Shin DD, Orlandi C, Gheorghiade M. Rossi J, et al. Among authors: gheorghiade m. Acute Card Care. 2007;9(2):82-6. doi: 10.1080/17482940701210179. Acute Card Care. 2007. PMID: 17573581 Clinical Trial.
Characterization and prognostic value of persistent hyponatremia in patients with severe heart failure in the ESCAPE Trial.
Gheorghiade M, Rossi JS, Cotts W, Shin DD, Hellkamp AS, Piña IL, Fonarow GC, DeMarco T, Pauly DF, Rogers J, DiSalvo TG, Butler J, Hare JM, Francis GS, Stough WG, O'Connor CM. Gheorghiade M, et al. Arch Intern Med. 2007 Oct 8;167(18):1998-2005. doi: 10.1001/archinte.167.18.1998. Arch Intern Med. 2007. PMID: 17923601 Clinical Trial.
Admission or changes in renal function during hospitalization for worsening heart failure predict postdischarge survival: results from the Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF).
Klein L, Massie BM, Leimberger JD, O'Connor CM, Piña IL, Adams KF Jr, Califf RM, Gheorghiade M; OPTIME-CHF Investigators. Klein L, et al. Among authors: gheorghiade m. Circ Heart Fail. 2008 May;1(1):25-33. doi: 10.1161/CIRCHEARTFAILURE.107.746933. Circ Heart Fail. 2008. PMID: 19808267
Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial.
Cuffe MS, Califf RM, Adams KF Jr, Benza R, Bourge R, Colucci WS, Massie BM, O'Connor CM, Pina I, Quigg R, Silver MA, Gheorghiade M; Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Cuffe MS, et al. Among authors: gheorghiade m. JAMA. 2002 Mar 27;287(12):1541-7. doi: 10.1001/jama.287.12.1541. JAMA. 2002. PMID: 11911756 Clinical Trial.
Rationale and design of the OPTIME CHF trial: outcomes of a prospective trial of intravenous milrinone for exacerbations of chronic heart failure.
Cuffe MS, Califf RM, Adams KF, Bourge RC, Colucci W, Massie B, O'Connor CM, Pina I, Quigg R, Silver M, Robinson LA, Leimberger JD, Gheorghiade M. Cuffe MS, et al. Among authors: gheorghiade m. Am Heart J. 2000 Jan;139(1 Pt 1):15-22. doi: 10.1016/s0002-8703(00)90303-x. Am Heart J. 2000. PMID: 10618557 Clinical Trial.
719 results